Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Qiagen (QGEN) Cash & Equivalents (2021 - 2026)

Qiagen's Cash & Equivalents history spans 13 years, with the latest figure at $646.3 million for Q1 2026.

  • On a quarterly basis, Cash & Equivalents rose 1.18% to $646.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $646.3 million, a 1.18% increase, with the full-year FY2025 number at $839.0 million, up 26.44% from a year prior.
  • Cash & Equivalents hit $646.3 million in Q1 2026 for Qiagen, down from $839.0 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for QGEN hit a ceiling of $1.4 billion in Q3 2025 and a floor of $359.2 million in Q1 2023.
  • Historically, Cash & Equivalents has averaged $740.8 million across 5 years, with a median of $668.1 million in 2023.
  • Biggest five-year swings in Cash & Equivalents: surged 105.91% in 2022 and later plummeted 54.39% in 2023.
  • Tracing QGEN's Cash & Equivalents over 5 years: stood at $730.7 million in 2022, then fell by 8.57% to $668.1 million in 2023, then decreased by 0.68% to $663.6 million in 2024, then grew by 26.44% to $839.0 million in 2025, then dropped by 22.97% to $646.3 million in 2026.
  • Business Quant data shows Cash & Equivalents for QGEN at $646.3 million in Q1 2026, $839.0 million in Q4 2025, and $1.4 billion in Q3 2025.